Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
As of close of business last night, MoonLake Immunotherapeutics’s stock clocked out at $13.39, up 0.98% from its previous closing price of $13.26. In other words, the price has increased by $0.98 from its previous closing price. On the day, 1.11 million shares were traded. MLTX stock price reached its highest trading level at $13.51 during the session, while it also had its lowest trading level at $13.09.
Ratios:
To gain a deeper understanding of MLTX’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 8.50 and its Current Ratio is at 8.50. In the meantime, Its Debt-to-Equity ratio is 0.26 whereas as Long-Term Debt/Eq ratio is at 0.26.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Dec 08 ’25 when Santos da Silva Jorge sold 130,000 shares for $15.08 per share. The transaction valued at 1,960,400 led to the insider holds 2,948,577 shares of the business.
Santos da Silva Jorge sold 70,000 shares of MLTX for $1,014,300 on Dec 09 ’25. The Chief Executive Officer now owns 2,878,577 shares after completing the transaction at $14.49 per share. On Dec 08 ’25, another insider, Reich Kristian, who serves as the Chief Scientific Officer of the company, sold 130,000 shares for $15.08 each. As a result, the insider received 1,960,400 and left with 72,908 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MLTX now has a Market Capitalization of 948646720 and an Enterprise Value of 550535872.
Stock Price History:
The Beta on a monthly basis for MLTX is 1.21, which has changed by -0.7431914 over the last 52 weeks, in comparison to a change of 0.14402747 over the same period for the S&P500. Over the past 52 weeks, MLTX has reached a high of $62.75, while it has fallen to a 52-week low of $5.95. The 50-Day Moving Average of the stock is 11.45%, while the 200-Day Moving Average is calculated to be -62.73%.
Shares Statistics:
It appears that MLTX traded 5.19M shares on average per day over the past three months and 1809000 shares per day over the past ten days. A total of 70.85M shares are outstanding, with a floating share count of 64.01M. Insiders hold about 9.65% of the company’s shares, while institutions hold 60.63% stake in the company. Shares short for MLTX as of 1764288000 were 4270493 with a Short Ratio of 0.82, compared to 1761868800 on 4907886. Therefore, it implies a Short% of Shares Outstanding of 4270493 and a Short% of Float of 11.9799994.
Earnings Estimates
Its stock is currently analyzed by 7.0 different market analysts. The consensus estimate for the next quarter is -$0.89, with high estimates of -$0.68 and low estimates of -$1.01.
Analysts are recommending an EPS of between -$3.46 and -$3.69 for the fiscal current year, implying an average EPS of -$3.58. EPS for the following year is -$3.58, with 10.0 analysts recommending between -$1.83 and -$4.36.
